In aftermath of the decision, the Sackler family, Purdue Pharma and lawyers for the plaintiffs expressed hope that a new deal could quickly be reached. As part of the original settlement ...

"Today, we are forcing Purdue Pharma and the Sackler family to pay $7.4 billion for their role in igniting one of the most devastating public health crises in American history." Purdue Pharma said ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...

Purdue Pharma and the Sackler family have agreed to increase by over $1 billion after the Supreme Court overturned a prior settlement in 2024. Judge pauses Trump funding freeze order until Feb. 3 ...

State AGs have reached a new opioid settlement worth $7.4 billion with Purdue Pharma and its owners. The settlement does not give Sackler family members immunity from future opioid lawsuits.

A narrowly divided Supreme Court in a 5-4 decision struck down a hard-fought bankruptcy plan for OxyContin manufacturer Purdue Pharma that ... to Purdue's owners, the Sackler family.

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication Oxycontin caused a widespread opioid ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement over the toll of the powerful prescription painkiller ...

Purdue Pharma’s Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation ...

NEW YORK, Feb 25 (Reuters) - Purdue Pharma told a U.S. bankruptcy judge on Tuesday that it will finalize a new bankruptcy plan in March, with the company's Sackler family owners potentially paying ...

Washington — The Supreme Court on Thursday derailed a multi-billion-dollar bankruptcy plan for Purdue Pharma, the maker ... agreement's broad protection for the Sackler family from civil ...

NEW YORK, Sept 5 (Reuters) - Purdue Pharma on Thursday received an 18-day extension of a years-long pause on litigation against its owners, members of the wealthy Sackler family, after convincing ...